Cuprina Holdings Receives MEDIFLY Product Classification in Saudi Arabia
Cuprina Holdings announced several strategic business developments, including a significant regulatory classification in Saudi Arabia and the expansion of its Medical and Scientific Advisory Board. Cuprina's 49%-owned associate, Cuprina MENA Co. Ltd, has received official product classification from the Saudi Food and Drug Authority for MEDIFLY, the Company's medical-grade maggot debridement therapy. The SFDA has classified MEDIFLY as a Medical Device-Drug combination product, with the primary mode of action regulated under the medical device framework. This classification, which allows the Company to finalize the scientific and technical requirements necessary for the commercial distribution of MEDIFLY across Saudi Arabia's healthcare network, is a critical milestone in Cuprina's expansion strategy for the Middle East and North Africa region. The Company is also pleased to announce the appointment of Enming Yong to its Medical and Scientific Advisory Board. Dr. Yong is a highly respected Consultant in the Department of Endocrinology at Tan Tock Seng Hospital and serves as an Adjunct Senior Lecturer at the Lee Kong Chian School of Medicine, both located in Singapore.
Trade with 70% Backtested Accuracy
Analyst Views on CUPR
About CUPR
About the author

- Nasdaq's IPO Leadership: Nasdaq is the leading U.S. stock exchange for initial public offerings (IPOs), hosting more than any other exchange.
- High Rate of Failed IPOs: The exchange is also known for a significant number of small IPOs that fail, resulting in substantial losses for public investors.
- Stock Price Warning: Cuprina Holdings received a noncompliance notice from Nasdaq due to its closing bid price failing to meet the $1 minimum requirement over the last 30 trading days, indicating significant market pressure on the company.
- Compliance Period: The company has a 180-day compliance period to regain its bid price, and if it achieves a closing price of at least $1 for ten consecutive days, it can avoid delisting, highlighting the urgency for Cuprina to act swiftly to ensure continued listing.
- Potential Consequences: If compliance is not regained within the specified timeframe, Cuprina may need to consider measures such as a reverse stock split to meet Nasdaq's other listing standards, reflecting the company's vulnerability in the capital markets.
- Ongoing Trading: Despite the warning, Cuprina's shares will continue to trade, indicating that the market remains cautious yet hopeful about the company's efforts to regain compliance in the future.

Warning of Pump-and-Dump Schemes: Edwin Dorsey, author of "The Bear Cave," has highlighted a surge in pump-and-dump stock schemes targeting thinly traded China-based stocks, with specific stocks like QMMM and Cuprina Holdings experiencing extreme price volatility.
Evidence of Manipulation: Stocks mentioned in Dorsey's report have shown significant price increases without substantial news, indicating potential manipulation, prompting Dorsey to launch a website to gather evidence against the scammers.

Market Performance: U.S. stocks showed mixed results, with the Nasdaq Composite gaining over 100 points, while the Dow fell 0.17%. The S&P 500 also saw an increase of 0.64%.
Sector Movements: Information technology stocks rose by 2.2%, while consumer discretionary stocks declined by 0.8%.
Notable Stock Changes: Chewy, Inc. shares dropped 14% despite exceeding earnings expectations, while Wearable Devices Ltd. surged 412% after reporting strong EPS results and securing a patent.
Global Market Trends: European and Asian markets closed higher, with the eurozone's STOXX 600 up 0.3% and Japan's Nikkei 225 gaining 0.87%. U.S. producer prices fell 0.1% month-over-month in August.

Oracle Corporation Earnings Report: Oracle's shares rose 29.6% in pre-market trading despite reporting first-quarter earnings of $1.47 per share, slightly below the analyst estimate of $1.48, and revenue of $14.92 billion, missing the expected $15.03 billion but showing growth from $13.3 billion year-over-year.
Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with Marwynn Holdings gaining 310.6% and Antelope Enterprise Holdings rising 238%, while QMMM Holdings and Epsium Enterprise experienced sharp declines of 60% and 54.4%, respectively.
Stock Surge: Cuprina Holdings (CUPR) shares soared 278.92% in after-hours trading to $2.66 after securing exclusive licensing rights for medical waste recycling technology in Southeast Asia.
Technology and Market Potential: The licensed technology, which uses high-temperature steam for waste sterilization, addresses Singapore's growing medical waste issue and taps into a rapidly expanding global medical waste management market projected to reach $59.42 billion by 2030.








